Core Insights - eXoZymes Inc. has launched BioClick, an innovative initiative aimed at enhancing enzyme engineering for advanced chemical reactions, supported by a $300K grant from the NIH [1][5] - BioClick focuses on group transfer reactions, inspired by Click Chemistry, enabling the development of more effective drugs through processes like prenylation [2][3] - The initiative introduces high-throughput screening capabilities, allowing rapid testing of enzyme variations, significantly reducing time and costs in drug development [3][4] Company Overview - eXoZymes, founded in 2019, has developed a biomanufacturing platform that utilizes AI-engineered enzymes to produce essential chemicals sustainably [6][7] - The company aims to replace traditional chemical production methods with eco-friendly alternatives, positioning itself as a leader in the next generation of biomanufacturing [8][9] Technological Advancements - The BioClick tool set incorporates artificial intelligence to automate the design of novel small molecules, enhancing the potential for new and improved drugs [4] - eXoZymes' exozymes are designed to operate outside living cells, overcoming limitations in synthetic biology and enabling scalable biosolutions [7][8]